KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Shares Repurchased (2017 - 2025)

Historic Shares Repurchased for Emergent BioSolutions (EBS) over the last 7 years, with Q3 2025 value amounting to $8.9 million.

  • Emergent BioSolutions' Shares Repurchased changed N/A to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $82.1 million for FY2022, which is 2254.72% down from last year.
  • Emergent BioSolutions' Shares Repurchased amounted to $8.9 million in Q3 2025.
  • Over the past 5 years, Emergent BioSolutions' Shares Repurchased peaked at $106.0 million during Q4 2021, and registered a low of $200000.0 during Q4 2022.
  • Its 3-year average for Shares Repurchased is $39.4 million, with a median of $24.4 million in 2022.
  • Examining YoY changes over the last 5 years, Emergent BioSolutions' Shares Repurchased showed a top increase of 9981.13% in 2022 and a maximum decrease of 9981.13% in 2022.
  • Quarter analysis of 3 years shows Emergent BioSolutions' Shares Repurchased stood at $106.0 million in 2021, then tumbled by 99.81% to $200000.0 in 2022, then skyrocketed by 4350.0% to $8.9 million in 2025.
  • Its Shares Repurchased stands at $8.9 million for Q3 2025, versus $200000.0 for Q4 2022 and $24.4 million for Q2 2022.